Clinical Trial Update: Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating chemotherapy with whole-body hyperthermia for resistant breast, endometrial, cervical, and ovarian cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cervical Cancer
• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• Chemotherapy with whole-body hyperthermia

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Breast Neoplasms, Endometrial Neoplasms | Phase 2 | Status: UNKNOWN